Skip to main content
Clinical Trials/CTRI/2021/06/034357
CTRI/2021/06/034357
Not yet recruiting
未知

Anaesthetic implications of post-COVID mucormycosis in a tertiary care hospital, West Bengal, India - Mucor, Anaesthesia

Dr Swati Datta0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B465- Mucormycosis, unspecified
Sponsor
Dr Swati Datta
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Swati Datta

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with RTPCR confirmed recent (with in last one \& a half months) infection with SARS\-COV\-2 and current RTPCR negative status
  • 2\. Presence of more than 1 of following clinical features:
  • i) Frontal headache
  • ii) Blurring of vision
  • iii) Numbness of chick
  • iv) Facial swelling
  • v) Features suggestive of cranial nerve involvement
  • vi) Nasal or sinus congestion
  • vii) Black lesion on nasal bridge or upper inside of mouth (palatal region)
  • 3\. Undergoing surgical resection of rhino\-orbito\-cerebral mucormycoses

Exclusion Criteria

  • 1\. COVID\-19 RTPCR positive mucormycosis
  • 2\. Patients with incomplete medical records
  • 3\. Post COVID mucormycosis patients who are critically ill, not undergoing surgical treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials